Introduction
============

In high-throughput datasets, sophisticated biostatistical analyses are required to see how technical and biological information of samples is reflected in the data. The variation inherent to the samples (biological variation) coexists with variation added by technical sources, such as batch effects, and random noise.[@b1-cin-12-2013-193] A landmark study has highlighted that technical biases in the form of batch effects are found in several high-dimensional data such as gene expression, protein data, and data from next-generation sequencing.[@b2-cin-12-2013-193] Data on epigenetic profiling[@b3-cin-12-2013-193] and copy number changes[@b4-cin-12-2013-193] may also be influenced by batch effects. The underlying cause of an observed batch effect is often unclear and may be linked to a variety of experimental conditions, such as reagent lot, date of experiment, or laboratory personnel. In a broader sense, the merging of several datasets into one single dataset also constitutes a batch effect problem.[@b5-cin-12-2013-193],[@b6-cin-12-2013-193] Undetected batch effects can have major impact on subsequent conclusions in both unsupervised and supervised analysis.[@b2-cin-12-2013-193] Several methods that remove or adjust batch variation have been developed. These methods range from simple batchwise centering of probes to more sophisticated methods, eg, ComBat,[@b7-cin-12-2013-193] DWD,[@b8-cin-12-2013-193] SVA,[@b9-cin-12-2013-193] and XPN;[@b10-cin-12-2013-193] however no clear best-performing method has emerged.[@b11-cin-12-2013-193],[@b12-cin-12-2013-193] It is worth noting that batch correction changes the data substantially and may be incomplete or may introduce new bias to the data. Therefore it is important to evaluate the quality of batch correction.

Herein we identify technical bias in datasets from commonly used high-throughput platforms and delineate problems of batch correction in such data. We then suggest a simple procedure to validate batch correction that can be conveniently applied using the R package *swamp*.

Methods
=======

Detection, correction and re-evaluation of technical bias
---------------------------------------------------------

We have developed the R package *swamp* to provide algorithms and supportive plots for the analyses of high-throughput data in respect to sample annotations. The basic elements of the suggested framework presented in [Figure 4](#f4-cin-12-2013-193){ref-type="fig"} are:

1.  Study design: Heatmap of the square matrix of log~10~*P*-values from pair-wise tests of sample annotations using Fisher/Chi-square test or linear models. Function: *confounding*.

2.  Principal component analysis, using univariate linear regression models to determine the association between principal components and sample annotations. A heatmap of log~10~*P*-values or R^2^ values is plotted. Functions: *prince, prince.plot*.

3.  Hierarchical clustering analysis and a quantification of batch effects across the dendrogram clusters using Fisher/Chi-square test or linear models for factors and numeric vectors respectively. Functions: *hca.plot, hca.test*.

4.  We include two data correction methods that so far have not been implemented in R packages: The function *kill.pc* removes principal components from the data, as described by Alter et al.[@b13-cin-12-2013-193] Principal components are deleted from the data by setting the corresponding singular values to zero and recalculating the data matrix. The function *adjust.linearmodel* uses the lm() function to obtain for each probe the residuals of a linear regression model with the technical variable as regressor. The *adjust.linearmodel* function makes it possible to correct the data for continuous technical variables. Furthermore we implemented the popular Com-Bat algorithm,[@b7-cin-12-2013-193] taken from the webpage <http://www.bu.edu/jlab/wp-assets/ComBat>, in the function *combat.* The functions *batchadjust.ref* and *bachadjust.zero* perform simple median-centering of each probe and batch.

Additional batch correction methods, which may be more appropriate for certain data types, can be found in dedicated R packages for dwd,[@b14-cin-12-2013-193] poe,[@b15-cin-12-2013-193] sva,[@b16-cin-12-2013-193] isva,[@b17-cin-12-2013-193] pls-sva,[@b18-cin-12-2013-193] and xpn.[@b12-cin-12-2013-193]

Data processing
---------------

For RNAseq data, we downloaded level3 RNAseqv2 data from the Cancer Genome Atlas (TCGA) data portal. We used the files that contain 'reads per kilo-base per million mapped reads' (RPKM) values for each gene. There is currently no standard processing pipeline of RPKM values. In the case of colon cancer, we used quantile-normalization as it removed substantial amounts of unexplained variation. For all RNAseq datasets from TCGA, we added an offset of 32, capped the data at 65,000, log2 transformed the data, and mean-centered the genes. This simple pre-processing method makes the data similar to the microarray gene expression format. It has been proposed that heteroscedastic RNAseq counts may influence downstream homoscedastic-based methods, such as principal component analysis.[@b19-cin-12-2013-193] We therefore compared the simple pre-processing method with 'variance stabilizing transformation' (vst).[@b19-cin-12-2013-193] However, we find that principal component analysis of TCGA data produces highly similar results for the simple pre-processing method and the vst-correction ([Supplementary Fig. 1](#s1-cin-12-2013-193){ref-type="supplementary-material"}). In order to limit unnecessary data transformation, we did not continue to use vst-corrected data. For miRNAseq data, we downloaded level3 data from the TCGA data portal and performed the same data pre-processing (offset 32, cap 65,000, log2 transformation).

For methylation data we downloaded level2 data and calculated beta-values as M/(M+U), where M is methylated and U is unmethylated signal. For microarray gene expression data we used processed data from Leek et al.[@b2-cin-12-2013-193] The batch variable in this dataset refers to date of hybridization, as derived from the headers of the cel files.

Availability and requirements
-----------------------------

The R package *swamp* is freely available at CRAN. The package runs in R 2.15 or higher, and requires *amap*, *gplots*, and *impute*[@b20-cin-12-2013-193] packages. A Windows software for *swamp* is freely available at <http://co.bmc.lu.se/swamp/>. The software is implemented in RGG language,[@b21-cin-12-2013-193] and requires R 2.15 or higher and Java.

Results
=======

Batch effects are found in a variety of datasets
------------------------------------------------

TCGA resource is remarkable as it reports technical variables in detail, notably by the MD Anderson Batch Effects Tool that implements the MBatch package. To visualize technical bias, such as batch effects, in high-throughput datasets, we introduce a plot which we call *prince* plot ([Fig. 1](#f1-cin-12-2013-193){ref-type="fig"}). For the *prince* plot we perform a univariate linear regression of each principal component of a data matrix using the sample annotations as regressors. The heatmap of *P*-values shows the strength of associations of each sample annotation with the top principal components of a dataset. Biological variables are well associated to the top principal components, as shown in [Figure 1](#f1-cin-12-2013-193){ref-type="fig"}, for several types of data, including RNAseq, miRNAseq, Methylation27K, and Affymetrix gene expression data. For instance, estrogen receptor status is strongly associated with top components of all three breast cancer datasets. In the kidney cancer RNAseq and miRNAseq data sets, histological grade and tumor stage are well associated with principal component 1. However, technical variables can also be associated to high-ranking principal components. In particular, the 'batch' annotations from TCGA data were associated to the top components in all types of investigated data ([Fig. 1](#f1-cin-12-2013-193){ref-type="fig"}). The 'batch' variable is not further defined in the TCGA project; however, in most datasets correlates well with 'tissue source site' (hospital), 'shipment date,' and 'plate-id' variables. Notably, the 'tissue source site' variable can introduce slightly different bias when compared to the 'batch' variable, as observed in the breast cancer RNAseq data ([Fig. 1](#f1-cin-12-2013-193){ref-type="fig"}). Sources of technical bias can also stem from continuous variables such as amount of DNA or RIN-value (RNA Integrity Number, ranges from 1 to 10) as observed in the kidney cancer RNAseq dataset. Furthermore, technical bias can occur in more than one principal component. For example, the batch variable of the lung cancer RNAseq data is associated with principal components 2, 3 and 4; and the strength of these associations differs across principal components. Biological variation may overlap technical variation and therefore can influence the same principal component. For example, principal component 2 of the bladder cancer expression data indicates that the technical 'batch' and the biological 'CIS' variables are interrelated. In summary, technical bias is present in all investigated high-throughput technologies, varies in effect size, and may overlap with biological variation in the data.

Monitoring of batch correction
------------------------------

We took RNAseq data from TCGA's colon cancer project generated using Illumina Hiseq2000 technology as an example.[@b22-cin-12-2013-193] To make the analysis straightforward, we considered only the four largest sample batches. A plot of the interrelation of some important biological and technical variables revealed information on the study design of the TCGA colon project ([Fig. 2A](#f2-cin-12-2013-193){ref-type="fig"}). The 'batch' variable overlaps with 'date-of-shipment' and 'plate-id,' as is the case for most TCGA projects. On the other hand, 'batch' is largely independent from biological variables such as 'MSI status' or 'MLH1 silencing,' indicating that each batch contains roughly the same biological composition. The *prince* plot shows that batch, together with other technical variables, confounds the first and the third component ([Fig. 2B](#f2-cin-12-2013-193){ref-type="fig"}). The biological variables are highly associated with the second principal component and show moderate association with the fourth component. As biological and technical variables are associated to different sets of principal components, they contribute to uncorrelated variation patterns. No conclusions can be made a priori on the unexplained variance in the principal component analysis. For example, the variance in component 5 could be caused by either unknown technical or unknown biological processes. Batch effects have an immediate impact on unsupervised clustering analysis, with samples from the same batch clustering together ([Fig. 2C](#f2-cin-12-2013-193){ref-type="fig"}). The two main colon cancer clusters are driven significantly by batch assignment (*P* = 2.5 × 10^−6^, Fisher test). We removed the first and third principal components from the dataset, as they are dominated by technical confounders and confirm the removal using a *prince* plot ([Fig. 2D](#f2-cin-12-2013-193){ref-type="fig"}). This resulted in the batch variable being equally distributed across the two main clusters ([Fig. 2E](#f2-cin-12-2013-193){ref-type="fig"}, *P* = 0.47). The TCGA publication concluded that *MYC* is a key regulator in colon cancer. We compared the associations of all genes on the platform to MYC expression, before and after correction ([Fig. 2F](#f2-cin-12-2013-193){ref-type="fig"}). Before correction, 2879 genes were correlated to MYC at fdr = 0.05 while 4757 genes were after correction. Furthermore, there were 2406 genes before correction and 3924 genes after correction correlated to micro-satellite instability, respectively. It should be emphasized that successful batch correction can also decrease associations in supervised analysis. This is the case when the technical variable and the biological variable of interest are correlated. In such cases, the initial biological effect had been inflated by the batch effect.

Monitoring of dataset merging
-----------------------------

In another example, two RNAseq datasets taken from the ReCount database were assessed.[@b23-cin-12-2013-193] Here, two labs used independently generated B-lymphocyte cell lines from the same 29 HapMap samples. A large association of the study variable was found with the first principal component of the merged data ([Fig. 3A](#f3-cin-12-2013-193){ref-type="fig"}), and corrected the data by setting the median of each probe to be the same in both studies. Gender remained associated to the data after correction ([Fig. 3B](#f3-cin-12-2013-193){ref-type="fig"}). The gender association is weak, however, as it relies on only 3 Y-chromosome genes, expressed in males. The highest expressed gene, *RPS4Y1*, shows increased male-specific expression after study correction (before: *P* = 6 × 10^−9^; after: *P* = 3 × 10^−15^). For a single HapMap individual, RNAseq data across the two studies should be similar. Before study correction sample pairs, however, are anti-correlated. This is due to the strong effect of the study variable in combination with low biological variation, as all cell lines are derived from lymphocytic cells of healthy individuals. Mean correlation values of HapMap cell line pairs increase after study correction, from −0.38 to 0.29 ([Fig. 3C](#f3-cin-12-2013-193){ref-type="fig"}).

Discussion
==========

We find that large RNAseq datasets, such as those generated by the TCGA,[@b22-cin-12-2013-193],[@b24-cin-12-2013-193]--[@b26-cin-12-2013-193] can be burdened with technical variation and that this bias distorts downstream analysis. For expression microarray data, it has been shown that standard normalization pipelines may perform poorly to remove batch effects.[@b2-cin-12-2013-193] In the colon RNA-seq dataset from TCGA, we applied quantile-normalization to RPKM values, thereby removing unexplained variances. However, batch effects remained after quantile-normalization. Applying a vst, as suggested for RNAseq data,[@b19-cin-12-2013-193] did not make a notable impact on the TCGA datasets. For sequencing technologies, it may be possible that platform-tailored alignment and pre-processing algorithms can reduce batch effects, and we would argue that the *prince* plot is an adequate tool to monitor improvements.

The high prevalence of batch effects has important implications on study design. As it is unclear how to avoid batch effects, it may be wise to consider a study design that allows for repairing batch effects. In the worst case, biological variables and technical variables are highly correlated, eg, Phenotype A was assayed preferentially on Date A, and Phenotype B was preferentially assayed on Date B. The removal of a batch effect in such a case will be problematic as it reduces the biological variation in the data. To be able to correct for batch effects, each batch should be a good representation of the overall cohort. If there remains a risk that a strong biological variable is unknown, randomization of samples across batches may be a good strategy. A sufficiently large number of samples per batch are needed to statistically secure biological independence of batches. When the data is a compendium of small batches, batch correction is likely to shift biological variation, and hence outweighs the benefits. Unfortunately, many TCGA batches show biological selection and are small-sized, which makes it problematic to provide batch-corrected data.

To control batch effects, we propose a simple framework ([Fig. 4](#f4-cin-12-2013-193){ref-type="fig"}). During the experiment all possible sources of technical variation are recorded and put into relation with biological annotations. The data is then screened by a *prince* plot and hierarchical clustering analysis. This may lead to detection of batch effects and subsequent batch correction efforts. If the correction algorithms provided by the *swamp* package are not suitable for a certain dataset, we encourage the use of an alternative algorithm from the literature. The choice of batch correction algorithm is likely to be dependent on study design,[@b12-cin-12-2013-193] pre-processing steps, sample type, and platform. Regardless of the chosen algorithm, it is important to monitor the success of batch correction. Therefore, the outcome of data manipulation is controlled again by a *prince* plot/HCA. The elements of this framework are implemented in the R package *swamp*.

Conclusions
===========

In summary, we find that high-throughput datasets which result in continuous measurements are potentially subject to technical biases. In such data, we argue that it is essential to monitor batch effects, eg, using the *prince* plot. Furthermore, we recommend a study design that keeps technical and biological variables independent, to be able to take rescue actions. To increase transparency and reproducibility of scientific findings, data submissions to public repositories should include technical variables.

Supplementary Figure
====================

###### 

Simple data processing vs. variance stabilizing transformation.

**Notes:** The *prince* plots show the log~10~*P*-values from univariate linear regression of the top 10 principal components with sample annotations as regressors. The *P*-values are color-coded from red (*P* \< 10^−8^) to white (*P* = 1). For sample annotations see [Figure 1](#f1-cin-12-2013-193){ref-type="fig"}.
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![Technical and biological variation in cancer high-throughput data.\
**Notes:** The *prince* plots show the log~10~*P*-values from univariate linear regression of the top 10 principal components with sample annotations as regressors. The *P*-values are color-coded from red (*P* \< 10^−8^) to white (*P* = 1). Sample annotations are named as in the TCGA biotab files or patient information tables of the respective TCGA portal publications.\
**Abbreviations:** TCGA, The Cancer Genome Atlas; CIS, carcinoma in situ.](cin-12-2013-193f1){#f1-cin-12-2013-193}

![Adjustment of the RNAseq data from the TCGA colorectal cancer project.\
**Notes:** The 4 largest batches of the colon cancer data are analyzed before and after data correction. (**A**) Confounding plot shows the association of sample annotations with *P*-values color-coded from purple (*P* \< 10^−8^) to white (*P* = 1). (**B**) *Prince* plot before correction. Legend as in [Figure 1](#f1-cin-12-2013-193){ref-type="fig"}, and percentage of variation for each principal component in brackets. (**C**) Hierarchical cluster analysis (HCA) using correlation as distance and ward algorithm as linkage method. MSI, microsatellite instability: green, stable microsatellites; red, MSI-low; black, MSI-high. (**D**) *Prince* plot after removal of principal components 1 and 3. (**E**) HCA after correction. (**F**) Correlation of the expression of all genes on the platform to MYC expression before (black) and after (green) correction.](cin-12-2013-193f2){#f2-cin-12-2013-193}

![Merging of two HapMap RNAseq datasets.\
**Notes:** RNAseq data of 29 HapMap cell lines from two independent studies. (**A**) *Prince* plot before study correction and (**B**) after correction. (**C**) Density plot of correlations of HapMap cell line pairs before (black) and after (red) study correction.](cin-12-2013-193f3){#f3-cin-12-2013-193}

![Framework to monitor technical variation.](cin-12-2013-193f4){#f4-cin-12-2013-193}
